Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of short-course radiotherapy versus total neoadjuvant therapy in older rectal cancer patients: a randomised pragmatic trial (SHAPERS).

ESMO gastrointestinal oncology·2026
Same author

Unlocking the therapeutic potential of immuno-radiotherapy: insights from preclinical and clinical research.

Oncoimmunology·2026
Same author

[Abscopal effect: Myth or reality?]

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2021
Same author

<i>In-vivo</i> and <i>in-vitro</i> impact of high-dose rate radiotherapy using flattening-filter-free beams on the anti-tumor immune response.

Clinical and translational radiation oncology·2020
Same author

RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort study.

EBioMedicine·2019
Same author

Tumor lymphocyte immune response to preoperative radiotherapy in locally advanced rectal cancer: The LYMPHOREC study.

Oncoimmunology·2018
Same journal

White paper on radiotherapy in France: Ten objectives to strengthen one of the major modalities of cancer treatment.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Contemporary survival outcomes of patients with isolated nodal recurrences of breast cancer: A population-based study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Factors affecting the stability of deep inspiration breath-holding in radiotherapy for left-sided breast cancers.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Incidence and outcomes of radiation-induced sarcomas following radiotherapy for low-grade non-Hodgkin lymphomas: A population-based study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Radiotherapy as a curative strategy for primary pleural indolent lymphomas: Analytical guidelines based on literature and an illustrative population-based case series.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Cone-beam computed tomography-based radiomics for tumour regression assessment during radiotherapy of non-small-cell lung cancer.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
See all related articles

Related Experiment Video

Updated: Jul 20, 2025

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.2K

Radiation-activated nanoparticles: Which combination to optimize radiosensitization?

S Penninckx1, P Martinive2, C Mirjolet3

  • 1Medical Physics Department, institut Jules-Bordet, Université libre de Bruxelles, 1070 Brussels, Belgium; Radiotherapy Department, institut Jules-Bordet, Université libre de Bruxelles, 1070 Brussels, Belgium.

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|August 6, 2023
PubMed
Summary
This summary is machine-generated.

Metal nanoparticles enhance radiotherapy by amplifying radiation dose and sensitizing cancer cells. Combining nanoparticle-enhanced radiotherapy with immunotherapy may improve anti-tumor immune responses for better cancer treatment outcomes.

Keywords:
ChemotherapyChimiothérapieCombinaisonCombinationImmunotherapyImmunothérapieNanoparticleNanoparticulePersonalizationPersonnalisationRadiotherapyRadiothérapie

More Related Videos

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.0K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.1K

Related Experiment Videos

Last Updated: Jul 20, 2025

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

12.2K
Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
08:57

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

11.0K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.1K

Area of Science:

  • Oncology
  • Nanotechnology
  • Radiation Oncology

Background:

  • Radiotherapy is a cornerstone of cancer treatment, with technological advances enabling precise tumor targeting.
  • Enhancing radiotherapy effectiveness through combination therapies is an active area of research.
  • Metal nanoparticles offer a promising strategy due to their dose-amplifying and radiosensitizing properties.

Approach:

  • Reviewing current literature on nanoparticle-radiotherapy combinations.
  • Exploring the mechanisms of metal nanoparticle action in radiosensitization.
  • Investigating the synergistic potential of combining nanoparticle-enhanced radiotherapy with immunotherapies.

Key Points:

  • Metal nanoparticles can locally amplify radiation dose deposition.
  • Nanoparticles modify cellular oxidative status, enhancing radiosensitivity.
  • Combining radiotherapy with nanoparticles and immunotherapy could improve local tumor control and systemic anti-tumor immunity.

Conclusions:

  • Nanoparticle-mediated dose enhancement and radiosensitization are key benefits.
  • The combination of radiotherapy, nanoparticles, and immunotherapy presents a novel therapeutic avenue.
  • Further research into these combined strategies holds promise for improved cancer treatment efficacy.